Skip to main content
Premium Trial:

Request an Annual Quote

Tom Waddell

Tom Waddell has joined Xagenic as a vice president to lead the company's product development. Waddell was most recently with the assay research group at Abbott Point of Care where he managed a team that developed new product prototypes. He also worked with an Abbott group involved in regulatory approval processes. Before joining Abbott, Waddell was at Pro-Lab Diagnostics where he was involved in taking diagnostic tools from design to approval. 

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.